BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Lyndra's long-acting oral drug delivery capsule a hoped for star on the horizon

Nov. 17, 2016
By Anette Breindl

Long-acting oral drug delivery star on horizon

Nov. 17, 2016
By Anette Breindl
A new drug delivery device that stays in the stomach and slowly releases its contents could replace daily pills with weekly or even monthly ones.
Read More

Bench Press: BioWorld looks at translational medicine

Nov. 14, 2016
By Anette Breindl
Autoimmune antibodies can ravage the body – or not: Many individuals have measurable autoantibodies for years before the onset of clinical symptoms, and even once clinical disease is present, antibody titers do not correlate with disease severity.
Read More

Cachexia is linked to immunotherapy failure

Nov. 14, 2016
By Anette Breindl
Researchers have linked metabolic changes in the wasting syndrome cachexia to the inability to mount an antitumor immune response.
Read More

Neurotransmitter GABA could be target for antidepressants

Nov. 11, 2016
By Anette Breindl
Currently, standard antidepressants – the selective serotonin reuptake inhibitors (SSRIs) – target serotonin. But serotonin is far from the only transmitter that is out of balance in depression.
Read More

Circuit-specific receptor targeting fights epilepsy

Nov. 10, 2016
By Anette Breindl
By targeting a so-called auxiliary protein, researchers have selectively inhibited specific neural circuits whose malfunction underlies one form of epilepsy.
Read More

'Strips' of heart tissue improve cardiac functio

Nov. 8, 2016
By Anette Breindl

Stimulating, blocking rapid-acting estrogen receptor both beneficial

Nov. 7, 2016
By Anette Breindl
"The average scientist thinks of estrogen as largely mediating gene expression," Eric Prossnitz told BioWorld Today. Estrogen is a steroid hormone, and its classical receptor is a nuclear hormone receptor that acts as a transcription factor once it is activated by estrogen binding.
Read More

Bench Press: BioWorld looks at translational medicine

Nov. 7, 2016
By Anette Breindl
After injury, zebrafish can send axons across severed spinal cords and regenerate neural connections. Now, researchers from Duke University have identified a molecule that is important for enabling them to do so.
Read More

'Strips' of heart tissue improve cardiac function

Nov. 4, 2016
By Anette Breindl
Researchers have been able to significantly improve the heart function of guinea pigs after an experimentally induced heart attack by transplanting the animals with sheets of induced pluripotent stem cell (iPSC)-derived human heart cells.
Read More
Previous 1 2 … 160 161 162 163 164 165 166 167 168 … 401 402 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • Glucagon-like peptide-1 receptor (GLP-1R) complex

    Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control

    BioWorld
    A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing